George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.44
Bid: 41.60
Ask: 41.70
Change: 0.56 (1.37%)
Spread: 0.10 (0.24%)
Open: 41.36
High: 41.70
Low: 40.84
Prev. Close: 40.88
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

13 Jan 2020 07:00

RNS Number : 5048Z
Assura PLC
13 January 2020
 

13 January 2020

Assura plc

 

Trading Update

For the third quarter ending 31 December 2019

 

Continued strong performance

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the third quarter ending 31 December 2019.

 

Jonathan Murphy, CEO, said:

 

"Assura continued to make strong progress in the third quarter. We expanded our market-leading portfolio with the acquisition of six high-quality assets and completed our third development of the year in Stow-on-the-Wold. We also grew our immediate pipeline of acquisition and development opportunities, reinforcing what was already our strongest in 10 years, to £252 million including 13 developments currently on site."

 

"With the new Government enshrining in law increased funding for the NHS and taking forward the Health Infrastructure Plan, better primary care facilities for patients, staff and services are at the heart of the agenda. In this context, Assura is well positioned to deliver high-quality assets and value for money for the NHS."

 

Building the portfolio

·; Current portfolio of 563 properties.

·; Development completed at Stow-on-the-Wold, taking total to three completed year to date at a total cost of £11.8 million.

·; Currently on site with 13 developments at the period end with a total development cost of £66 million.

·; Six acquisitions completed in the period at a cost of £31.1 million; four disposals made for cash proceeds of £1.0 million.

 

Expanding the pipeline

·; Immediate development pipeline further increased to £90 million, up from £72 million at September 2019.

·; Immediate acquisitions pipeline further increased to £96 million, up from £65 million at September 2019.

·; Total immediate pipeline, including on site developments, worth £252 million, up from £206 million at September 2019.

 

Growing the rent roll

·; Five lease re-gears completed in the quarter taking cumulative year-to-date re-gears to 18. These leases represent £1.7 million of the Group's rent roll, adding a weighted average of 10.2 years WAULT to those 18 leases.

·; Annualised rent roll at £105.8 million taking account of additions, disposals and rent reviews.

 

Robust balance sheet

·; As at 31 December 2019 gross debt stood at £787 million with undrawn facilities of £280 million.

 

As previously announced, the quarterly dividend has been increased to 0.697 pence per share with effect from January 2020. This is equivalent to 2.788 pence per share on an annualised basis.

 

ENDS

 

 

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFERLEIILII
Date   Source Headline
19th Oct 202012:13 pmRNSDirector/PDMR Shareholding
12th Oct 20204:54 pmRNSScrip Dividend Declaration
7th Oct 202012:11 pmRNSDirector/PDMR Shareholding
7th Oct 202012:05 pmRNSCorrection to Trading Update
7th Oct 20207:00 amRNSTrading Update
25th Sep 20201:50 pmRNSHolding(s) in Company
23rd Sep 202012:07 pmRNSDirector/PDMR Shareholding
17th Sep 202010:30 amRNSScrip Calculation Price
16th Sep 20207:00 amRNSVirtual Property Tour
8th Sep 20204:19 pmRNSPricing of £300m Social Bond
4th Sep 20202:36 pmRNSDirector/PDMR Shareholding
4th Sep 20202:34 pmRNSAdditional Listing
3rd Sep 20201:31 pmRNSNotice of Dividend
20th Aug 20203:02 pmRNSNotification of Major Interests in Shares
3rd Aug 202011:11 amRNSDirector/PDMR Shareholding
24th Jul 20203:04 pmRNSExercise of Nil Cost Options under PSP
21st Jul 20207:00 amRNSAdditional Listing
16th Jul 20207:00 amRNSDirector/PDMR Shareholding
14th Jul 202012:54 pmRNSPDMR Notification
9th Jul 20207:00 amRNSScrip Dividend Declaration
8th Jul 20201:42 pmRNSNotification of Major Interests in Shares
7th Jul 20203:12 pmRNSResult of AGM
7th Jul 20207:00 amRNSTrading update
1st Jul 20201:25 pmRNSNotification of Major Interests in Shares
24th Jun 20208:00 amRNSNotification of Major Interests in Shares
18th Jun 20202:43 pmRNSScrip Calculation Price
15th Jun 20205:15 pmRNSNotification of Major Interests in Shares
12th Jun 20203:54 pmRNSDirector/PDMR Shareholding
12th Jun 202011:47 amRNSAmended Notice of AGM
9th Jun 20202:04 pmRNSAnnual Report and Notice of AGM
4th Jun 202010:01 amRNSNotice of dividend
21st May 20207:00 amRNSAssura Full Year Results
11th May 20207:00 amRNSConfirmation of announcement date for results
16th Apr 202010:50 amRNSDirector/PDMR Shareholding
14th Apr 202012:38 pmRNSReplacement Scrip Dividend Declaration
14th Apr 20207:00 amRNSNotification of Major Interests in Shares
14th Apr 20207:00 amRNSNotification of Major Interests in Shares
9th Apr 20207:00 amRNSScrip Dividend Declaration
7th Apr 20207:00 amRNSResults of Placing
6th Apr 20204:42 pmRNSProposed equity placing of new ordinary shares
2nd Apr 20207:00 amRNSTrading update
20th Mar 20207:00 amRNSScrip Calculation Price
13th Mar 20204:46 pmRNSNotification of Major Interests in Shares
5th Mar 20207:00 amRNSNotice of Dividend
24th Feb 20203:40 pmRNSNotification of Major Interests in Shares
20th Feb 20209:13 amRNSNotification of Major Interests in Shares
17th Jan 202011:27 amRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSScrip dividend declaration
13th Jan 20207:00 amRNSTrading update
6th Jan 202012:11 pmRNSNotification of Major Interests in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.